Your browser doesn't support javascript.
loading
Preclinical characterization and validation of a dual-labeled trastuzumab-based imaging agent for diagnosing breast cancer.
Wang, Xuejuan; Aldrich, Melissa B; Marshall, Milton V; Sevick-Muraca, Eva M.
Afiliação
  • Wang X; 1 Department of Nuclear Medicine, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China ; 2 Division of Molecular Imaging, The Brown Foundation Institute of Molecular Medicine, University of Texas
  • Aldrich MB; 1 Department of Nuclear Medicine, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China ; 2 Division of Molecular Imaging, The Brown Foundation Institute of Molecular Medicine, University of Texas
  • Marshall MV; 1 Department of Nuclear Medicine, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China ; 2 Division of Molecular Imaging, The Brown Foundation Institute of Molecular Medicine, University of Texas
  • Sevick-Muraca EM; 1 Department of Nuclear Medicine, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China ; 2 Division of Molecular Imaging, The Brown Foundation Institute of Molecular Medicine, University of Texas
Chin J Cancer Res ; 27(1): 74-82, 2015 Feb.
Article em En | MEDLINE | ID: mdl-25717229

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Ano de publicação: 2015 Tipo de documento: Article